Draft:Diagnapy
| Submission declined on 22 November 2024 by Wikishovel (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Neologisms are not considered suitable for Wikipedia unless they receive substantial use and press coverage; this requires strong evidence in independent, reliable, published sources. Links to sites specifically intended to promote the neologism itself do not establish its notability.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 22 November 2024 by Qcne (talk). Wikipedia is an encyclopedia and not a dictionary. We cannot accept articles that are little more than definitions of words or abbreviations as entries. A good article should begin with a good definition, but expand on the subject. You might try creating a definition for this instead at Wiktionary, which is a dictionary. Please only do so if it meets that sister project's criteria for inclusion. These require among others, attestation for the word or phrase, as verified through clear widespread use, or its use in permanently recorded media, conveying meaning, in at least three independent instances spanning at least a year. Declined by Qcne 24 days ago. | |
Term first coined by Dr. Gary Kohanbash in November of 2024 to indicate a study focused on both diagnosis ("diagn"-) and therapy (-"apy"). The initial description of Diagnapy was focused on using T-cells within tumors to both predict outcome as a diagnostic and for identification of novel antigens for personalized cancer therapy.